HomeREGULATORY
REGULATORY

Regulators Will Be Involved in Safety Data Transition for LLP Withdrawals: MHLW Official
(Nov.30.2017)

Pharmaceutical Management Director Tomonori Nakayama (left), Medical Economics Division Director Masami Sakoi before Chuikyo Industry Hearing
Regulatory authorities will be involved in efforts to ensure the smooth transition of safety information and other data when original drug makers decide to pull their long-listed products (LLPs) off the market under a newly proposed LLP rule, a health ministry official said on November 29 ...
(LOG IN FOR FULL STORY)

News Calendar